Ads
related to: heart failure meds list- Clinical Data
Clinical Trial Data For HCPs.
Learn More About Heart Failure.
- Clinical Trail Safety
Proven Safety Profile In Patients.
Review Clinical Research & Data.
- Coverage
Lowest Branded Copay Access.
Search For Coverage In Your Area.
- Patient Coverage
Pay As Little As $10.
Search For Patient Coverage.
- Clinical Data
assistantmagic.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The following are medications commonly prescribed cardiac pharmaceutical agents. The specificity of the following medications is highly variable, and often are not particularly specific to a given class. As such, they are listed as are commonly accepted.
They are indicated to treat diseases related to the heart or the vascular system (blood vessels), such as hypertension, hyperlipidemia, coagulation disorders, heart failure and coronary artery disease. [1] These drugs are prescription-only medicines, meaning that they should be administered strictly under a doctor’s instruction and can only ...
Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia ...
Antiarrhythmic medications. Prescribed for heart failure and arrhythmia, these drugs work on the heart’s electrical system to improve heart function and decrease the risk of arrhythmia.
This group of drugs is often used as adjunctive therapy, in combination with other drugs, for the management of chronic heart failure. Spironolactone, the first member of the class, is also used in the management of hyperaldosteronism (including Conn's syndrome) and female hirsutism (due to additional antiandrogen actions).
The related medication eplerenone was shown in the EPHESUS trial [31] to have a similar effect, and it is specifically labelled for use in decompensated heart failure complicating acute myocardial infarction. While the antagonism of aldosterone will decrease the effects of sodium and water retention, it is thought that the main mechanism of ...
Heart failure with recovered ejection fraction (HFrecovEF or HFrecEF): patients previously with HFrEF with complete normalization of left ventricular ejection (≥50%). [64] [65] Heart failure may also be classified as acute or chronic. Chronic heart failure is a long-term condition, usually kept stable by the treatment of symptoms.
Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors ...
Ads
related to: heart failure meds listassistantmagic.com has been visited by 10K+ users in the past month